From Cricket Bans to Binding Pockets: Building Mental Models for Viral Glycoproteins in VR

From Cricket Bans to Binding Pockets: Building Mental Models for Viral Glycoproteins in VR The notification hit my phone at 11:47 PM on a Tuesday. EU bans house cricket protein in food products — EFSA cites insufficient safety data on allergen cross-reactivity. I stared at the screen, thumb hovering. Three years of grant proposals, late-night sequencing runs, and that one spectacular failure with the cryo-EM grid — all circling back to a regulatory footnote about insects I'd never even held. My lab works on viral glycoproteins. Not crickets. But the EFSA panel's reasoning — "structural homology between invertebrate tropomyosin and cricket allergens cannot be excluded" — used the exact language I'd written in Aim 2 of my last R01. Structural homology. The phrase that makes reviewers nod and structural biologists flinch. I learned to flinch in 2019, standing in front of a 300 kV Titan Krios at 3 AM. My sample: a prefusion-stabilized glycoprotein from a novel Orthomyxovirus isolated from bat guano in Yunnan. Six months of expression optimization. Three weeks of grid screening. The 2D classes looked beautiful — clean particles, clear secondary structure. Then the 3D refinement stalled at 4.2 Å. The receptor-binding domain? A blur. The fusion peptide? Invisible. "Resolution isn't the problem," my postdoc said, rotating the map on a 27-inch monitor. "It's the flexibility. The RBD breathes. You're averaging open and closed states." We tried focused classification. Signal subtraction. Multi-body refinement. The map split into two conformations at 3.8 Å each — better, but the hinge region between head and stalk remained a ghost density. I could see the problem in my head: a glycoprotein breathing like a lung, sampling states that no single static structure could capture. But I couldn't show it. Not to my co-PI. Not to the program officer. Not even to myself, really — not in a way that let me trace the allosteric path from receptor engagement to fusion triggering. The cricket ban notification pulled me back to that ghost density. Structural homology. The EFSA panel had compared cricket tropomyosin to known arthropod allergens using sequence alignment and predicted structures from AlphaFold2. Predicted. Not determined. They'd built a mental model from static snapshots and called it sufficient for regulation. I understood the pragmatism. I also understood the danger. Viruses don't care about static snapshots. Influenza HA samples pre-fusion, intermediate, and post-fusion states. SARS-CoV-2 Spike rocks between up and down RBD conformations. HIV Env is a metastable spring-loaded trap. The binding pockets that matter — for antibodies, for receptors, for drug design — exist in the transitions. The pockets that don't exist in any single crystal structure. I'd spent two years trying to communicate this to collaborators using PyMOL sessions, chimeraX movies, and carefully annotated supplemental figures. "Look here," I'd say, screen-sharing a rotated density map. "See how this loop moves?" They'd nod. Then ask for the coordinates of the "open state" so they could dock compounds. Into a pocket that only exists for 12 nanoseconds in a 500-nanosecond simulation. The VR headset sat in its box for six months. A departmental purchase — "exploratory visualization for structural biology" — that arrived right before the pandemic locked down the building. I'd tried it once, loaded a ribosome structure, felt nauseous, and put it away. But the cricket ban email came with a secondary thought: What if the EFSA panel could walk through the homology model? What if they could see where the predicted epitope sits relative to the tropomyosin coiled-coil — not as a ribbon diagram, but as a space they inhabit? I dug out the headset. Updated firmware. Installed the molecular viewer our computational core had been developing — a Unity-based tool that streams MD trajectories from the cluster, lets you scrub time like a video, highlights hydrogen bonds on gaze, measures distances with pinch gestures. Loaded the bat virus glycoprotein. The 500-ns trajectory we'd run on Anton2. 50,000 frames. The first time I stood inside the prefusion trimer, the nausea vanished. Not because the tech improved — the field of view was still narrow, the refresh rate still 72 Hz. But my brain stopped fighting the coordinate system. I wasn't rotating a model on a screen. I was the coordinate system. The RBD breathing motion — that ghost density — became a corridor. I walked through the hinge region at frame 12,000. The loop that refused to resolve in cryo-EM? It swung open like a gate. A pocket formed between protomers — hydrophobic, transient, lined with conserved residues we'd mutated in 2021 and lost infectivity. There. That's the pocket. Not in the open state. Not in the closed state. In the transition. I scrubbed backward. Forward. The pocket appeared at frame 11,840. Disappeared at 12,110. 270 frames. 2.7 nanoseconds. "Can you save that conformation?" my postdoc asked over Slack when I screen-cast the view. "Which one? It's not a conformation. It's a trajectory." The cricket connection turned out to be literal. Our computational core had a visiting student from Wageningen — insect allergens, not viruses. She'd loaded the AlphaFold2-predicted cricket tropomyosin dimer into the same viewer. "Want to see why EFSA is nervous?" We stood together in the coiled-coil. The predicted IgE epitope — a surface-exposed helix — sat at the dimer interface. But the prediction showed it buried. "AlphaFold gives the ground state," she said. "Allergens unfold in the gut. The epitope gets exposed during digestion." "Can you simulate that?" "Not with our resources. But—" She loaded a 200-ns simulation of tropomyosin at low pH. "Watch the helix." In VR, the coiled-coil didn't just melt. It breathed. The epitope helix peeled away in rhythmic pulses — 3.2 nanoseconds exposed, 8.7 buried, repeating. A dynamic epitope. Invisible to static structure. Invisible to sequence alignment. "EFSA used a static homology model," I said. "They compared a snapshot of cricket protein to snapshots of known allergens. But the danger isn't in the snapshot. It's in the breathing." That conversation changed how I write aims. Aim 2 of the new R01 doesn't say "determine structures of intermediate states." It says: Characterize the conformational landscape of viral glycoprotein receptor engagement using integrative structural biology and immersive trajectory analysis, identifying cryptic pockets that exist only along transition paths. The preliminary data section includes a QR code linking to a WebXR session. Reviewers can put on a $300 headset and walk through the bat virus RBD transition themselves. Stand in the pocket that exists for 2.7 nanoseconds. Measure the distance between residue 156 and 342 as it changes. See the water molecules rearrange. One reviewer wrote: "The immersive visualization is a gimmick. The science is in the coordinates." Another: "Finally, a structural biologist who understands that dynamics are not noise — they're the mechanism." The second reviewer got it. The first one will, eventually. They all will. Last week, I got an email from the Wageningen student. She's defending her thesis. The title: Dynamic Epitope Exposure in Food Allergens: Beyond Static Homology Modeling. She'd used the VR viewer to convince her committee that a predicted "safe" cricket protein variant — engineered to remove the static epitope — still exposed the same region during simulated gastric unfolding. The variant failed. The static model said it would pass. "Your bat virus taught me how to see my crickets," she wrote. "Thanks for the headset time." I smiled at the screen. Then opened the new trajectory — a coronavirus spike from a pangolin sample, 1.2 microseconds, the longest we've ever run. The RBD up-down transition is messy. Three protomers, asynchronous, coupled through the stalk. The pocket I want — for a broad-spectrum inhibitor — might not exist in any single frame. It might be a consensus of transient sub-pockets across the ensemble. I put on the headset. The lab is quiet. 2 AM. The cluster hums in the server room down the hall. In here, I'm standing at the base of a viral spike taller than I am, watching three receptor-binding domains dance. A pocket flickers open between protomer A and B. Then B and C. Then all three simultaneously — a three-fold symmetric gasp that lasts 400 picoseconds. I pinch to measure. Dictate a note. Flag the frames. This is the mental model. Not the structure. Not even the trajectory. The intuition built by inhabiting the dynamics — the same intuition that lets a cricket allergy researcher see danger in a "safe" sequence, and a virologist see a drug target in a ghost density. The headset is heavy. My eyes are tired. But the pocket is real. I'll find it in the morning — in the coordinates, in the mutagenesis, in the inhibitor screen. But tonight, I already know where to look. If you've ever rotated a density map and felt the frustration of static snapshots trying to capture a breathing machine — there's a different way to see it. The tools are here. The trajectories are waiting. You just have to step inside.